✦ LIBER ✦

Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome

✍ Scribed by P. Van Damme; R. Vrackx; A. Meheus

Book ID: 119150800
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 298 KB
Volume: 8
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(90)90236-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of a recombinant hepatiti

Immunogenicity of a recombinant hepatitis B vaccine in children with down syndrome. A controlled study

✍ A.I. Lopes; M. Palba; J. Charlston; C. Barrades; M. Pedro; J.Salazar Sousa 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Immunogenicity of a recombinant DNA hepa

Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients

✍ A.F. Lefebure; G.A. Verpooten; M.M. Couttenye; M.E. De Broe 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Immunogenicity of a heat-treated recombi

Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine

✍ M. Just; R. Berger 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Immunogenicity of a recombinant hepatiti

Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff

✍ S.A. Teles; R.M.B. Martins; C.L.R. Lopes; M.A. dos Santos Carneiro; K.P. Souza; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 360 KB

Immunogenicity of a recombinant hepatiti

Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs

✍ P. M. Mannucci; A. Gringeri; M. Morfini; R. De Biasi; M. C. Tirindelli; G. Tampo 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 2 views

Immunogenicity of a yeast-recombinant he

Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children

✍ M. G. Rumi; R. Romeo; M. Bortolini; A. Gringeri; A. R. Zanett; P. M. Mannucci; M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

Horizontal transmission of hepatitis B virus (HBV) from illicit drug users to their contacts, including young children, can be prevented by active immunization against HBV. Yeast-recombinant hepatitis B vaccines are now available for this purpose, but their potential efficacy in such high-risk conta